PGA-ARQ-501

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePGA-ARQ-501
Drug Alias Namepolyglutamic-ARQ-501ARQ-501 conjugate (Arqule)PGA-ARQ-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE2F transcription factors stimulantsDNA topoisomerase I inhibitors
TargetsE2F transcription factorsDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArqule Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArqule Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A